← back to search

Yael David

Memorial Sloan Kettering Cancer Center · US
Area of research
Molecular Biology
Research interest
Research interests include Epigenetics and DNA Methylation, Genomics and Chromatin Dynamics, RNA Research and Splicing, and RNA modifications and cancer.
h-index
27
citations
2,611
works
79
NIH funding
primary concept
email

Recent publications

Bidirectional histone monoaminylation dynamics regulate neural rhythmicity
Nature 2025cited by 42position: middledoi
Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation
Cell 2025cited by 36position: middledoi
A nucleosome switch primes hepatitis B virus infection
Cell 2025cited by 25position: lastdoi
A needed nomenclature for nucleosomes
Molecular Cell 2025cited by 9position: middledoi
The molecular basis of Human FN3K mediated phosphorylation of glycated substrates
Nature Communications 2025cited by 8position: middledoi
Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
Nature Cancer 2024cited by 25position: middledoi
Epigenetic dysregulation from chromosomal transit in micronuclei
Nature 2023cited by 114position: middledoi
Nature-inspired protein ligation and its applications
Nature Reviews Chemistry 2023cited by 62position: lastdoi
Single-stranded nucleic acid binding and coacervation by linker histone H1
Nature Structural & Molecular Biology 2022cited by 71position: middledoi
Chromatin sequesters pioneer transcription factor Sox2 from exerting force on DNA
Nature Communications 2022cited by 49position: middledoi
Chemical Labeling and Enrichment of Histone Glyoxal Adducts
ACS Chemical Biology 2022cited by 36position: middledoi
Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 18position: middledoi
Non-enzymatic Covalent Modifications as a New Chapter in the Histone Code
Trends in Biochemical Sciences 2021cited by 42position: lastdoi
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Haematologica 2021cited by 11position: middledoi
Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture
Nature 2020cited by 263position: middledoi
H1 histones control the epigenetic landscape by local chromatin compaction
Nature 2020cited by 191position: middledoi
Non-enzymatic covalent modifications: a new link between metabolism and epigenetics
Protein & Cell 2020cited by 88position: lastdoi
An Azidoribose Probe to Track Ketoamine Adducts in Histone Ribose Glycation
Journal of the American Chemical Society 2020cited by 30position: lastdoi
Reversible histone glycation is associated with disease-related changes in chromatin architecture
Nature Communications 2019cited by 185position: lastdoi
Bisphosphoglycerate mutase controls serine pathway flux via 3-phosphoglycerate
Nature Chemical Biology 2017cited by 82position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qingfei Zheng · The Ohio State University6 papers (2019–2023) · 4 papers (2020–2022) · 3 papers (2019–2022)Shixin Liu · Tianjin University of Traditional Chinese Medicine3 papers (2019–2022)Tuan Nguyen · Cornell University2 papers (2022–2022) · 2 papers (2020–2022)Tom W. Muir · Princeton University2 papers (2017–2022)John W. Watters · Rockefeller University2 papers (2022–2022)James J. Galligan · University of Arizona2 papers (2020–2022) · 2 papers (2022–2025)Rachel Leicher · Rockefeller University2 papers (2019–2022)Robert E. Thompson · Princeton University1 papers (2022–2022)Htet Ng · Rockefeller University1 papers (2022–2022)Li Shen · Allen Institute for Brain Science1 papers (2022–2022)Sasha L. Fulton · Allen Institute for Brain Science1 papers (2022–2022)Jeremy Chang · Cornell University1 papers (2022–2022) · 1 papers (2022–2022)Malin Hultcrantz · Memorial Sloan Kettering Cancer Center1 papers (2021–2021)Nicholas Adrian Prescott · The University of Texas at Austin1 papers (2025–2025)Efrat Finkin-Groner · Hebrew University of Jerusalem1 papers (2019–2019)